SlideShare a Scribd company logo
1 of 26
DR CHAMINDA AMARASEKARA
Resident Surgery
Armed Forces Medical College
Pune
 Urinary calculi are very common disease of urinary
tract
 The incidence of urinary tract stone disease is
increasing*
*Epidemiological data of National Health and Nutrition Examination
Survey (USA)
2
4/30/2023
ASICON 2016 Mysuru
To study the clinical outcomes of patients who have
undergone ESWL for Renal stones
MATERIAL AND METHODS
This study was done in the Department of Urology, of a
tertiary care military hospital
Study design: Prospective observational study
Study group:
All patients diagnosed as having renal calculi (size0.5cm
to 2.5cm).
3
4/30/2023
ASICON 2016 Mysuru
Exclusion criteria
 Radiolucent stones
 Age <18 yrs
 Stone size >2.5cm & Stone size< 0.5cm
 Repeated presentation who undergone ESWL
 All absolute contraindication for ESWL
Pregnancy.
Uncorrected bleeding diatheses.
Uncontrolled urinary tract infections.
Severe skeletal malformations and severe obesity
Arterial aneurysm in the vicinity of the stone treated.
Anatomical obstruction distal to the stone
4
4/30/2023
ASICON 2016 Mysuru
 STATISTICAL METHODS
◦ SPSS version 19
◦ Chi square test, paired “t” test used for comparative
analysis
◦ ‘P’ value of 0.05 was taken as significant
 Equipment
Electro Magnetic
Lithotripter
(Make- Dornier Compact Delta )
5
Dornier Compact Delta
Electro Magnetic Lithotripter
4/30/2023
ASICON 2016 Mysuru
Age ( years) Frequency %
16 - 25 15 10.00%
26 - 35 48 32.00%
36 - 45 32 21.33%
46 - 55 19 12.67%
56 - 65 26 17.33%
66 - 75 10 6.67%
Demographic data of the patients
Age distribution.
6
Description Age(yrs)
Mean(SD) 42.13(14.09)
Range 18 - 73
RESULTS
4/30/2023
ASICON 2016 Mysuru
Sex Frequency Percent Ratio
Female 41 27.33% 1
Male 109 72.67% 2.65
Gender description.
7
4/30/2023
ASICON 2016 Mysuru
Co morbidities Frequency %
Diabetes Mellitus 25 16.67%
Hypertension 22 14.67%
Parkinsonism 1 0.67%
IHD 1 0.67%
NIL 109 72.66%
Co-morbidity status
8
4/30/2023
ASICON 2016 Mysuru
Description Duration of Illness (weeks)
Mean 25.77(15.11)
Range 3 – 52
Description of duration.
Description of no of episodes
Number of Episodes Frequency %
1st 128 85.33%
2nd or more 22 14.67%
9
4/30/2023
ASICON 2016 Mysuru
Pain Frequency %
No 5 3.33%
Yes 145 96.67%
Description of chief complaints.
10
4/30/2023
ASICON 2016 Mysuru
11
62.33%
12.98%
9.09%
5.19%
2.59%
7.79%
CaC4O4
Mixed
Mg NH3
PO4
Ca3(
PO4)2
CaCO3
Chemical composition of Stones
4/30/2023
ASICON 2016 Mysuru
Pain n
Mean
size SD
P value
Yes 145 1.48 0.43
0.894
No 5 1.44 0.56
Size of stone and pain.
12
4/30/2023
ASICON 2016 Mysuru
Location
Pain
Total
P value
Yes % No %
Lower 33
94.29
2
5.71
35
0.742
Middle 72 97.30 2 2.70 74
Upper 37 97.37 1 2.63 38
Pelvic 3 100.0 0 0.00 3
Table 9 Location of the stone and pain
13
4/30/2023
ASICON 2016 Mysuru
Haematuria Frequency %
Gross 2 1.33%
Microscopic 53 35.33%
Absent 95 63.33%
Description of haematuria.
14
4/30/2023
ASICON 2016 Mysuru
Haematuria n
Mean
size SD P-value
Present 55 1.42 0.37
0.238
Absent 95 1.51 0.47
Stone size and haematuria.
15
4/30/2023
ASICON 2016 Mysuru
Location Hematuria Total
P value
Present % Absent %
Lower 12 34.29 23 65.71 35
0.299
Middle 32 42.67 42 57.33 74
Upper 11 31.58 27 68.42 38
Pelvic 0 0.00 3 100.0 3
Total 55 95 150
Location of stone and haematuria
16
4/30/2023
ASICON 2016 Mysuru
UTI Frequency %
Absent 113 75.33%
Present 37 24.66%
Associated urinary tract infection.
17
54.05%
32.43%
8%
5.40%
Ecoli
Proteus
Klebsiella
Enterococcus Sp
Urine culture
4/30/2023
ASICON 2016 Mysuru
Description Size of Stone
Mean(SD) 1.47(.43)
Range 0.80 - 2.50
Stone Size
Size description.
Location Frequency %
Lower 35 23.33%
Pelvis 3 2.66 %
Mid 74 49.33%
Upper 38 24.67%
Anatomical locations of stones.
18
4/30/2023
ASICON 2016 Mysuru
Stone size and number of sittings.
No of
sittings
n Mean S D Min Max P value
1 16 1.09 0.37 .80 2.20
<0.001
2 38 1.30 0.36 .80 2.30
3 48 1.47 0.33 .80 2.30
4 48 1.76 0.43 .80 2.50
total 150 1.48 0.44 .80 2.50
10.67%
25.33%
32.00%
32.00%
Number of Sittings
1.0
2.0
3.0
4.0
19
4/30/2023
ASICON 2016 Mysuru
Complications of ESWL
Complications Frequency %
Hematuria 30 20.00%
Loin pain 48 32.00%
UTI 7 4.67%
Dysuria 1 0.67%
Steinstrasse 5 3.33%
Total no of patients 91 60.66%
20
4/30/2023
ASICON 2016 Mysuru
Clinical evaluation in 1st review
7.34%
13.34%
1.34%
2.00%
76%
Hematuria
Loin pain
UTI
Steinsrrasse
Asymptomatic
21
4/30/2023
ASICON 2016 Mysuru
Clinical evaluation in 2nd review
*Had residual calculi
98.67%
Hematuria
Loin pain
UTI
Steinsrrasse
Asymptomatic
22
4/30/2023
ASICON 2016 Mysuru
 Extra corporal shock wave lithotripsy was introduced
in 1983.
 The clinical outcome of ESWL depends on
◦ size
◦ location
◦ chemical composition of the stone
23
4/30/2023
ASICON 2016 Mysuru
 More common among male gender
◦ male and female was 1.7:1 as per a study done by Scale C
D et al [1]
 Age group of 40 -60 yrs
◦ Strope SA et al showed the age group 40-60 yrs having highest
incidence of urolithiasis [2]
 Calcium oxalate
◦ Bangash K et al, showed that calcium oxalate was the
commonest chemical type of stones (87.5%)[3]
 Pain is the commonest symptom of renal stones
Pearle MS et al illustrated that 48.1% had pain , 25.9%
presented with gross haematuria, 14.3% had microscopic
hematuria and [6]
24
4/30/2023
ASICON 2016 Mysuru
 E - Coli is the commonest
◦ E- coli were the commonest among patients with urinary tract
stones[4]
 Larger stones required more number of sittings for
stone clearance
◦ Joshi HN et al in relation to size of the stone and respective
stone free rates were concluded as <1cm, 1-1.5 cm and > 1.5
cm was 97%, 97% and 90% [5]
 Following ESWL 98% patients become
asymptomatic after three months time
◦ Joshi HN et al 95.4% within three months of follow up after
completion of ESWL [5]
25
4/30/2023
ASICON 2016 Mysuru
26
Reference
1.Scales CD Jr, Curtis LH, Norris RD. Changing gender prevalence of
stone disease. J Urol. 2007; 177:979–82.
2. Strope SA, Wolf JS Jr, Hollenbeck BK. Changes in gender
distribution of urinary stone disease. Urology. 2010; 75:543-6.
3. Bangash K, Shigri F, Jamal A, and Anwar K. Spectrum of Renal
Stones Composition; Chemical Analysis of Renal Stones. International
Journal of Pathology. 2011; 9(2): 63-66
4. Mohammed A. Kadir, Majida N. Ibrahim ,Najeeba M. Salih.
prevalence of urinary tract infections in patients with renal stones. J.
Ayub Med. Coll. Abbottabad ; 2010: 20: 60-62
5. Joshi HN, Karmacharya RM, Shrestha R, Shrestha B, de Jong IJ,
Shrestha RK. Outcomes of extra corporeal shock wave lithotripsy in
renal and ureteral calculi. Kathmandu Univ Med J (KUMJ). 2014 Jan-
Mar;12(45):51-4.
Pearle MS, Calhoun EA, Curhan GC. Urologic Diseases in America
project: urolithiasis. J Urol. 2005; 173:848–57
4/30/2023
ASICON 2016 Mysuru

More Related Content

Similar to A CLINICAL STUDY OF OUTCOMES FOLLOWING ESWL FOR.pptx

Endoscopy in Gastrointestinal Oncology - Slide 14 - J. East - Endoscopy in pa...
Endoscopy in Gastrointestinal Oncology - Slide 14 - J. East - Endoscopy in pa...Endoscopy in Gastrointestinal Oncology - Slide 14 - J. East - Endoscopy in pa...
Endoscopy in Gastrointestinal Oncology - Slide 14 - J. East - Endoscopy in pa...
European School of Oncology
 
Oxford Record Linkage Study
Oxford Record Linkage StudyOxford Record Linkage Study
Oxford Record Linkage Study
suchiey
 
POUR AANS 1226 presentation A. Bashee[1]
POUR AANS 1226 presentation A. Bashee[1]POUR AANS 1226 presentation A. Bashee[1]
POUR AANS 1226 presentation A. Bashee[1]
Azam Basheer
 
Histomorphological Spectrum of Bone Lesions at Tertiary Care Centre
Histomorphological Spectrum of Bone Lesions at Tertiary Care Centre Histomorphological Spectrum of Bone Lesions at Tertiary Care Centre
Histomorphological Spectrum of Bone Lesions at Tertiary Care Centre
SSR Institute of International Journal of Life Sciences
 
Urgent Early Laparoscopic Reassessment
Urgent Early Laparoscopic ReassessmentUrgent Early Laparoscopic Reassessment
Urgent Early Laparoscopic Reassessment
George S. Ferzli
 

Similar to A CLINICAL STUDY OF OUTCOMES FOLLOWING ESWL FOR.pptx (20)

Dall'esofago di Barrett all'adenocarcinoma: fisiopatologia e diagnosi - Gas...
Dall'esofago di Barrett all'adenocarcinoma: fisiopatologia e diagnosi  -  Gas...Dall'esofago di Barrett all'adenocarcinoma: fisiopatologia e diagnosi  -  Gas...
Dall'esofago di Barrett all'adenocarcinoma: fisiopatologia e diagnosi - Gas...
 
Inductive Study of ESWL Outcomes for Proximal and Distal Ureteric Stones
Inductive Study of ESWL Outcomes for Proximal and Distal Ureteric StonesInductive Study of ESWL Outcomes for Proximal and Distal Ureteric Stones
Inductive Study of ESWL Outcomes for Proximal and Distal Ureteric Stones
 
Gastrointestinal-Pancreatic NET management
Gastrointestinal-Pancreatic NET managementGastrointestinal-Pancreatic NET management
Gastrointestinal-Pancreatic NET management
 
Endoscopy in Gastrointestinal Oncology - Slide 14 - J. East - Endoscopy in pa...
Endoscopy in Gastrointestinal Oncology - Slide 14 - J. East - Endoscopy in pa...Endoscopy in Gastrointestinal Oncology - Slide 14 - J. East - Endoscopy in pa...
Endoscopy in Gastrointestinal Oncology - Slide 14 - J. East - Endoscopy in pa...
 
A Cytological Study of Osteolytic Bone Lesions with Intact Cortex
A Cytological Study of Osteolytic Bone Lesions with Intact CortexA Cytological Study of Osteolytic Bone Lesions with Intact Cortex
A Cytological Study of Osteolytic Bone Lesions with Intact Cortex
 
Cancer Control in Australia
Cancer Control in Australia  Cancer Control in Australia
Cancer Control in Australia
 
Oxford Record Linkage Study
Oxford Record Linkage StudyOxford Record Linkage Study
Oxford Record Linkage Study
 
NSAIDs ASA GI protection
NSAIDs ASA GI protectionNSAIDs ASA GI protection
NSAIDs ASA GI protection
 
Ruzsa Z - AIMRADIAL 2014 Endovascular - Carotid artery stenting
Ruzsa Z - AIMRADIAL 2014 Endovascular - Carotid artery stentingRuzsa Z - AIMRADIAL 2014 Endovascular - Carotid artery stenting
Ruzsa Z - AIMRADIAL 2014 Endovascular - Carotid artery stenting
 
4 dr mario sideri m k
4  dr mario sideri  m k4  dr mario sideri  m k
4 dr mario sideri m k
 
POUR AANS 1226 presentation A. Bashee[1]
POUR AANS 1226 presentation A. Bashee[1]POUR AANS 1226 presentation A. Bashee[1]
POUR AANS 1226 presentation A. Bashee[1]
 
Interventional Endoscopic Ultrasound (EUS)
Interventional Endoscopic Ultrasound (EUS)Interventional Endoscopic Ultrasound (EUS)
Interventional Endoscopic Ultrasound (EUS)
 
Osteoradionecrosis - Dr. Amit T. Suryawanshi (MDS).Kolhapur, Sangli & Pune.
Osteoradionecrosis - Dr. Amit T. Suryawanshi (MDS).Kolhapur, Sangli & Pune.Osteoradionecrosis - Dr. Amit T. Suryawanshi (MDS).Kolhapur, Sangli & Pune.
Osteoradionecrosis - Dr. Amit T. Suryawanshi (MDS).Kolhapur, Sangli & Pune.
 
Corrosive injury review article and management.pptx
Corrosive injury review article and management.pptxCorrosive injury review article and management.pptx
Corrosive injury review article and management.pptx
 
Role of CT Urography in bladder cancer. Cambridge lecture.
Role of CT Urography in bladder cancer. Cambridge lecture.Role of CT Urography in bladder cancer. Cambridge lecture.
Role of CT Urography in bladder cancer. Cambridge lecture.
 
OIU review article
OIU  review articleOIU  review article
OIU review article
 
Evaluation Of Aetiology Of Upper Gastro Intestinal Bleeding &Management In Th...
Evaluation Of Aetiology Of Upper Gastro Intestinal Bleeding &Management In Th...Evaluation Of Aetiology Of Upper Gastro Intestinal Bleeding &Management In Th...
Evaluation Of Aetiology Of Upper Gastro Intestinal Bleeding &Management In Th...
 
Histomorphological Spectrum of Bone Lesions at Tertiary Care Centre
Histomorphological Spectrum of Bone Lesions at Tertiary Care Centre Histomorphological Spectrum of Bone Lesions at Tertiary Care Centre
Histomorphological Spectrum of Bone Lesions at Tertiary Care Centre
 
Urgent Early Laparoscopic Reassessment
Urgent Early Laparoscopic ReassessmentUrgent Early Laparoscopic Reassessment
Urgent Early Laparoscopic Reassessment
 
Uretero-Enteric Anastomosis Stricture after Urinary Diversion; Detailed Analy...
Uretero-Enteric Anastomosis Stricture after Urinary Diversion; Detailed Analy...Uretero-Enteric Anastomosis Stricture after Urinary Diversion; Detailed Analy...
Uretero-Enteric Anastomosis Stricture after Urinary Diversion; Detailed Analy...
 

More from Chaminda Amarasekara (6)

STERILIZATION & DISINFECTION PROCEDURES new - final.pptx
STERILIZATION & DISINFECTION PROCEDURES new - final.pptxSTERILIZATION & DISINFECTION PROCEDURES new - final.pptx
STERILIZATION & DISINFECTION PROCEDURES new - final.pptx
 
Surgical Treatment of Malignant Melanoma-1.ppt
Surgical Treatment of Malignant Melanoma-1.pptSurgical Treatment of Malignant Melanoma-1.ppt
Surgical Treatment of Malignant Melanoma-1.ppt
 
woundcare_SkinGraft.ppt
woundcare_SkinGraft.pptwoundcare_SkinGraft.ppt
woundcare_SkinGraft.ppt
 
Mailgnant melanoma
Mailgnant melanoma Mailgnant melanoma
Mailgnant melanoma
 
Stoma in surgery
Stoma in surgeryStoma in surgery
Stoma in surgery
 
Sterilization & disinfection procedures
Sterilization & disinfection procedures Sterilization & disinfection procedures
Sterilization & disinfection procedures
 

Recently uploaded

SPLICE Working Group: Reusable Code Examples
SPLICE Working Group:Reusable Code ExamplesSPLICE Working Group:Reusable Code Examples
SPLICE Working Group: Reusable Code Examples
Peter Brusilovsky
 
SURVEY I created for uni project research
SURVEY I created for uni project researchSURVEY I created for uni project research
SURVEY I created for uni project research
CaitlinCummins3
 
Contoh Aksi Nyata Refleksi Diri ( NUR ).pdf
Contoh Aksi Nyata Refleksi Diri ( NUR ).pdfContoh Aksi Nyata Refleksi Diri ( NUR ).pdf
Contoh Aksi Nyata Refleksi Diri ( NUR ).pdf
cupulin
 
Spellings Wk 4 and Wk 5 for Grade 4 at CAPS
Spellings Wk 4 and Wk 5 for Grade 4 at CAPSSpellings Wk 4 and Wk 5 for Grade 4 at CAPS
Spellings Wk 4 and Wk 5 for Grade 4 at CAPS
AnaAcapella
 

Recently uploaded (20)

Graduate Outcomes Presentation Slides - English (v3).pptx
Graduate Outcomes Presentation Slides - English (v3).pptxGraduate Outcomes Presentation Slides - English (v3).pptx
Graduate Outcomes Presentation Slides - English (v3).pptx
 
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptxCOMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
 
VAMOS CUIDAR DO NOSSO PLANETA! .
VAMOS CUIDAR DO NOSSO PLANETA!                    .VAMOS CUIDAR DO NOSSO PLANETA!                    .
VAMOS CUIDAR DO NOSSO PLANETA! .
 
24 ĐỀ THAM KHẢO KÌ THI TUYỂN SINH VÀO LỚP 10 MÔN TIẾNG ANH SỞ GIÁO DỤC HẢI DƯ...
24 ĐỀ THAM KHẢO KÌ THI TUYỂN SINH VÀO LỚP 10 MÔN TIẾNG ANH SỞ GIÁO DỤC HẢI DƯ...24 ĐỀ THAM KHẢO KÌ THI TUYỂN SINH VÀO LỚP 10 MÔN TIẾNG ANH SỞ GIÁO DỤC HẢI DƯ...
24 ĐỀ THAM KHẢO KÌ THI TUYỂN SINH VÀO LỚP 10 MÔN TIẾNG ANH SỞ GIÁO DỤC HẢI DƯ...
 
The Story of Village Palampur Class 9 Free Study Material PDF
The Story of Village Palampur Class 9 Free Study Material PDFThe Story of Village Palampur Class 9 Free Study Material PDF
The Story of Village Palampur Class 9 Free Study Material PDF
 
e-Sealing at EADTU by Kamakshi Rajagopal
e-Sealing at EADTU by Kamakshi Rajagopale-Sealing at EADTU by Kamakshi Rajagopal
e-Sealing at EADTU by Kamakshi Rajagopal
 
UChicago CMSC 23320 - The Best Commit Messages of 2024
UChicago CMSC 23320 - The Best Commit Messages of 2024UChicago CMSC 23320 - The Best Commit Messages of 2024
UChicago CMSC 23320 - The Best Commit Messages of 2024
 
8 Tips for Effective Working Capital Management
8 Tips for Effective Working Capital Management8 Tips for Effective Working Capital Management
8 Tips for Effective Working Capital Management
 
Sternal Fractures & Dislocations - EMGuidewire Radiology Reading Room
Sternal Fractures & Dislocations - EMGuidewire Radiology Reading RoomSternal Fractures & Dislocations - EMGuidewire Radiology Reading Room
Sternal Fractures & Dislocations - EMGuidewire Radiology Reading Room
 
SPLICE Working Group: Reusable Code Examples
SPLICE Working Group:Reusable Code ExamplesSPLICE Working Group:Reusable Code Examples
SPLICE Working Group: Reusable Code Examples
 
Trauma-Informed Leadership - Five Practical Principles
Trauma-Informed Leadership - Five Practical PrinciplesTrauma-Informed Leadership - Five Practical Principles
Trauma-Informed Leadership - Five Practical Principles
 
The Liver & Gallbladder (Anatomy & Physiology).pptx
The Liver &  Gallbladder (Anatomy & Physiology).pptxThe Liver &  Gallbladder (Anatomy & Physiology).pptx
The Liver & Gallbladder (Anatomy & Physiology).pptx
 
SURVEY I created for uni project research
SURVEY I created for uni project researchSURVEY I created for uni project research
SURVEY I created for uni project research
 
Stl Algorithms in C++ jjjjjjjjjjjjjjjjjj
Stl Algorithms in C++ jjjjjjjjjjjjjjjjjjStl Algorithms in C++ jjjjjjjjjjjjjjjjjj
Stl Algorithms in C++ jjjjjjjjjjjjjjjjjj
 
AIM of Education-Teachers Training-2024.ppt
AIM of Education-Teachers Training-2024.pptAIM of Education-Teachers Training-2024.ppt
AIM of Education-Teachers Training-2024.ppt
 
TỔNG HỢP HƠN 100 ĐỀ THI THỬ TỐT NGHIỆP THPT TOÁN 2024 - TỪ CÁC TRƯỜNG, TRƯỜNG...
TỔNG HỢP HƠN 100 ĐỀ THI THỬ TỐT NGHIỆP THPT TOÁN 2024 - TỪ CÁC TRƯỜNG, TRƯỜNG...TỔNG HỢP HƠN 100 ĐỀ THI THỬ TỐT NGHIỆP THPT TOÁN 2024 - TỪ CÁC TRƯỜNG, TRƯỜNG...
TỔNG HỢP HƠN 100 ĐỀ THI THỬ TỐT NGHIỆP THPT TOÁN 2024 - TỪ CÁC TRƯỜNG, TRƯỜNG...
 
How To Create Editable Tree View in Odoo 17
How To Create Editable Tree View in Odoo 17How To Create Editable Tree View in Odoo 17
How To Create Editable Tree View in Odoo 17
 
Contoh Aksi Nyata Refleksi Diri ( NUR ).pdf
Contoh Aksi Nyata Refleksi Diri ( NUR ).pdfContoh Aksi Nyata Refleksi Diri ( NUR ).pdf
Contoh Aksi Nyata Refleksi Diri ( NUR ).pdf
 
How to Manage Website in Odoo 17 Studio App.pptx
How to Manage Website in Odoo 17 Studio App.pptxHow to Manage Website in Odoo 17 Studio App.pptx
How to Manage Website in Odoo 17 Studio App.pptx
 
Spellings Wk 4 and Wk 5 for Grade 4 at CAPS
Spellings Wk 4 and Wk 5 for Grade 4 at CAPSSpellings Wk 4 and Wk 5 for Grade 4 at CAPS
Spellings Wk 4 and Wk 5 for Grade 4 at CAPS
 

A CLINICAL STUDY OF OUTCOMES FOLLOWING ESWL FOR.pptx

  • 1. DR CHAMINDA AMARASEKARA Resident Surgery Armed Forces Medical College Pune
  • 2.  Urinary calculi are very common disease of urinary tract  The incidence of urinary tract stone disease is increasing* *Epidemiological data of National Health and Nutrition Examination Survey (USA) 2 4/30/2023 ASICON 2016 Mysuru
  • 3. To study the clinical outcomes of patients who have undergone ESWL for Renal stones MATERIAL AND METHODS This study was done in the Department of Urology, of a tertiary care military hospital Study design: Prospective observational study Study group: All patients diagnosed as having renal calculi (size0.5cm to 2.5cm). 3 4/30/2023 ASICON 2016 Mysuru
  • 4. Exclusion criteria  Radiolucent stones  Age <18 yrs  Stone size >2.5cm & Stone size< 0.5cm  Repeated presentation who undergone ESWL  All absolute contraindication for ESWL Pregnancy. Uncorrected bleeding diatheses. Uncontrolled urinary tract infections. Severe skeletal malformations and severe obesity Arterial aneurysm in the vicinity of the stone treated. Anatomical obstruction distal to the stone 4 4/30/2023 ASICON 2016 Mysuru
  • 5.  STATISTICAL METHODS ◦ SPSS version 19 ◦ Chi square test, paired “t” test used for comparative analysis ◦ ‘P’ value of 0.05 was taken as significant  Equipment Electro Magnetic Lithotripter (Make- Dornier Compact Delta ) 5 Dornier Compact Delta Electro Magnetic Lithotripter 4/30/2023 ASICON 2016 Mysuru
  • 6. Age ( years) Frequency % 16 - 25 15 10.00% 26 - 35 48 32.00% 36 - 45 32 21.33% 46 - 55 19 12.67% 56 - 65 26 17.33% 66 - 75 10 6.67% Demographic data of the patients Age distribution. 6 Description Age(yrs) Mean(SD) 42.13(14.09) Range 18 - 73 RESULTS 4/30/2023 ASICON 2016 Mysuru
  • 7. Sex Frequency Percent Ratio Female 41 27.33% 1 Male 109 72.67% 2.65 Gender description. 7 4/30/2023 ASICON 2016 Mysuru
  • 8. Co morbidities Frequency % Diabetes Mellitus 25 16.67% Hypertension 22 14.67% Parkinsonism 1 0.67% IHD 1 0.67% NIL 109 72.66% Co-morbidity status 8 4/30/2023 ASICON 2016 Mysuru
  • 9. Description Duration of Illness (weeks) Mean 25.77(15.11) Range 3 – 52 Description of duration. Description of no of episodes Number of Episodes Frequency % 1st 128 85.33% 2nd or more 22 14.67% 9 4/30/2023 ASICON 2016 Mysuru
  • 10. Pain Frequency % No 5 3.33% Yes 145 96.67% Description of chief complaints. 10 4/30/2023 ASICON 2016 Mysuru
  • 12. Pain n Mean size SD P value Yes 145 1.48 0.43 0.894 No 5 1.44 0.56 Size of stone and pain. 12 4/30/2023 ASICON 2016 Mysuru
  • 13. Location Pain Total P value Yes % No % Lower 33 94.29 2 5.71 35 0.742 Middle 72 97.30 2 2.70 74 Upper 37 97.37 1 2.63 38 Pelvic 3 100.0 0 0.00 3 Table 9 Location of the stone and pain 13 4/30/2023 ASICON 2016 Mysuru
  • 14. Haematuria Frequency % Gross 2 1.33% Microscopic 53 35.33% Absent 95 63.33% Description of haematuria. 14 4/30/2023 ASICON 2016 Mysuru
  • 15. Haematuria n Mean size SD P-value Present 55 1.42 0.37 0.238 Absent 95 1.51 0.47 Stone size and haematuria. 15 4/30/2023 ASICON 2016 Mysuru
  • 16. Location Hematuria Total P value Present % Absent % Lower 12 34.29 23 65.71 35 0.299 Middle 32 42.67 42 57.33 74 Upper 11 31.58 27 68.42 38 Pelvic 0 0.00 3 100.0 3 Total 55 95 150 Location of stone and haematuria 16 4/30/2023 ASICON 2016 Mysuru
  • 17. UTI Frequency % Absent 113 75.33% Present 37 24.66% Associated urinary tract infection. 17 54.05% 32.43% 8% 5.40% Ecoli Proteus Klebsiella Enterococcus Sp Urine culture 4/30/2023 ASICON 2016 Mysuru
  • 18. Description Size of Stone Mean(SD) 1.47(.43) Range 0.80 - 2.50 Stone Size Size description. Location Frequency % Lower 35 23.33% Pelvis 3 2.66 % Mid 74 49.33% Upper 38 24.67% Anatomical locations of stones. 18 4/30/2023 ASICON 2016 Mysuru
  • 19. Stone size and number of sittings. No of sittings n Mean S D Min Max P value 1 16 1.09 0.37 .80 2.20 <0.001 2 38 1.30 0.36 .80 2.30 3 48 1.47 0.33 .80 2.30 4 48 1.76 0.43 .80 2.50 total 150 1.48 0.44 .80 2.50 10.67% 25.33% 32.00% 32.00% Number of Sittings 1.0 2.0 3.0 4.0 19 4/30/2023 ASICON 2016 Mysuru
  • 20. Complications of ESWL Complications Frequency % Hematuria 30 20.00% Loin pain 48 32.00% UTI 7 4.67% Dysuria 1 0.67% Steinstrasse 5 3.33% Total no of patients 91 60.66% 20 4/30/2023 ASICON 2016 Mysuru
  • 21. Clinical evaluation in 1st review 7.34% 13.34% 1.34% 2.00% 76% Hematuria Loin pain UTI Steinsrrasse Asymptomatic 21 4/30/2023 ASICON 2016 Mysuru
  • 22. Clinical evaluation in 2nd review *Had residual calculi 98.67% Hematuria Loin pain UTI Steinsrrasse Asymptomatic 22 4/30/2023 ASICON 2016 Mysuru
  • 23.  Extra corporal shock wave lithotripsy was introduced in 1983.  The clinical outcome of ESWL depends on ◦ size ◦ location ◦ chemical composition of the stone 23 4/30/2023 ASICON 2016 Mysuru
  • 24.  More common among male gender ◦ male and female was 1.7:1 as per a study done by Scale C D et al [1]  Age group of 40 -60 yrs ◦ Strope SA et al showed the age group 40-60 yrs having highest incidence of urolithiasis [2]  Calcium oxalate ◦ Bangash K et al, showed that calcium oxalate was the commonest chemical type of stones (87.5%)[3]  Pain is the commonest symptom of renal stones Pearle MS et al illustrated that 48.1% had pain , 25.9% presented with gross haematuria, 14.3% had microscopic hematuria and [6] 24 4/30/2023 ASICON 2016 Mysuru
  • 25.  E - Coli is the commonest ◦ E- coli were the commonest among patients with urinary tract stones[4]  Larger stones required more number of sittings for stone clearance ◦ Joshi HN et al in relation to size of the stone and respective stone free rates were concluded as <1cm, 1-1.5 cm and > 1.5 cm was 97%, 97% and 90% [5]  Following ESWL 98% patients become asymptomatic after three months time ◦ Joshi HN et al 95.4% within three months of follow up after completion of ESWL [5] 25 4/30/2023 ASICON 2016 Mysuru
  • 26. 26 Reference 1.Scales CD Jr, Curtis LH, Norris RD. Changing gender prevalence of stone disease. J Urol. 2007; 177:979–82. 2. Strope SA, Wolf JS Jr, Hollenbeck BK. Changes in gender distribution of urinary stone disease. Urology. 2010; 75:543-6. 3. Bangash K, Shigri F, Jamal A, and Anwar K. Spectrum of Renal Stones Composition; Chemical Analysis of Renal Stones. International Journal of Pathology. 2011; 9(2): 63-66 4. Mohammed A. Kadir, Majida N. Ibrahim ,Najeeba M. Salih. prevalence of urinary tract infections in patients with renal stones. J. Ayub Med. Coll. Abbottabad ; 2010: 20: 60-62 5. Joshi HN, Karmacharya RM, Shrestha R, Shrestha B, de Jong IJ, Shrestha RK. Outcomes of extra corporeal shock wave lithotripsy in renal and ureteral calculi. Kathmandu Univ Med J (KUMJ). 2014 Jan- Mar;12(45):51-4. Pearle MS, Calhoun EA, Curhan GC. Urologic Diseases in America project: urolithiasis. J Urol. 2005; 173:848–57 4/30/2023 ASICON 2016 Mysuru

Editor's Notes

  1. Statistical methods: SPSS version 19 was used for evaluation of results. Chi square test, paired “t” test used for comparative analysis and a ‘P’ value of 0.05 was taken as significant
  2. Age Distribution Mean age of the patients of this study group was 42.13 yrs (18-73 yrs). The maximum number of patients was in the age group between 26-35 yrs (32%) (Table 1&2).
  3. Out of 150 patients, 41(27.33%) were females and 109(72.67%) were males. Male to female ratio was 2.65: 1 (Table 3).
  4. Out of 150 patients 25(16.67%) had diabetes mellitus, 22(14.67%) had hypertension 1(0.67%) had parkinsonism, 1(0.67%) had ischemic heart disease(IHD) and 109(72.66%) patients were free of comorbidities (Table 4).
  5. 1.Mean duration of the presenting complain as per the history was 25.77 weeks (3 – 52) (Table 5 ) 2. Out of 150 patients 128(85.33%) patients presented as fresh cases and 22(14.67) presented with past history of stone diseases (Table 6).
  6. Main presenting complaint of the study group was pain. Out of 150 patients, 145 (96.67%) had pain of various clinical grades. Only 5(3.33%) patients did not complaint pain and renal stones were incidental findings in those cases (Table 6).
  7. Chemical composition of Stones In this study group 77 patients underwent chemical analysis of voided stone particles. Calcium Oxalate (CaC2O4) stones were found among 48(62.33%) patients, 10(12.98%) patients had mixed stones, 7(9.09%)patients had Struvite (MgNH4PO4.6H2O) stones, 4(5.19%) patients had Calcium Phosphate(Ca3(PO4)2)stones, 2(2.59%) patients had Calcium Carbonate (CaCO3) and 6(7.79%) patients had uric acid stones
  8. Pain in relation to size of the renal stones Mean size of the renal stones of patients who presented with pain was 1.48cm and without pain was 1.44 cm. There was no statistical significance between stone size and pain as presenting complaint, p value was 0.894 (Table 9).
  9. There was no statistical significance between location of stone and pain as a presenting complaint, p value was 0.742 (Table 10).
  10. Haematuria was a common presentation which 53(35.33%) showed microscopically and 2(1.33%) patient presented with gross haematuria. However 95(63.33%) patient did not have haematuria (Table 11
  11. There was no statistically significant relationship with stone size and haematuria P value was 0.238 (Table 13).
  12. There was no statistically significant association with location of stones and haematuria, P value was 0.299 (Table 14).
  13. Associated Urinary tract infection (UTI) In this study group 37(24.66%) patients had concomitant UTI and 113(75.36%) had sterile culture. Urinary culture of UTI patients showed the growth of E. coli 20(54.05%), Proteus 12(32.43%), Klebsiella 3(8%) and Enterococcus Sp 2(5.4%) (Table 15
  14. Anatomical locations of stones Middle zone of the caliceal system (CS) of the kidney was found to be the commonest anatomical location of stones 74(48%). Upper CS stones were found in 38(24.67%) patients, Lower CS stones among 35(23.33%) patients and pelvic stones in 3(4%) patients
  15. Number of sittings and size of the stones Mean stone size of the group which achieved complete stone clearance with single sitting was 1.09 cm mean stone size of the group which required 2 sittings for complete stone clearance was 1.3cm group which required 3 sittings the mean stone size was 1.47 mean size of the stone which patients required four sittings was 1.76cm
  16. Total 428 sittings of ESWL being given for 150 numbre of patients in which 91(60.66%) patients developed complications. Commonest complication was loin pain which 48(32%) presented with, hematuria was observed among 30(20%) patients, UTI 7(4.67%), steinstrasse 5(3.33%) and dysuria (culture sterile) 1(0.67%). Most of the complications are self limited or managed with OPD basis and fully recovered by subsequent visits (Table 49).
  17. Protocol follow up was done in one month and three months after completion of treatment
  18. mixed stones, MgNH4PO4 (struvite)stones, Ca3(PO4)2 stones, and uric acid stones are the different chemical composition in descending order of frequency